--- title: "Gosuncn expects a pre-loss, with a projected net loss of 220 million to 320 million yuan for the year 2024, indicating an expanded loss" type: "News" locale: "en" url: "https://longbridge.com/en/news/225825471.md" description: "According to the Zhitong Finance APP, Gosuncn has released its performance forecast for 2024. The company expects a net loss attributable to shareholders of the listed company to be between 220 million yuan and 320 million yuan, with losses widening; the net loss after deducting non-recurring gains and losses is expected to be between 282 million yuan and 382 million yuan, also with losses widening" datetime: "2025-01-22T11:01:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/225825471.md) - [en](https://longbridge.com/en/news/225825471.md) - [zh-HK](https://longbridge.com/zh-HK/news/225825471.md) generator: "portal-rs" --- # Gosuncn expects a pre-loss, with a projected net loss of 220 million to 320 million yuan for the year 2024, indicating an expanded loss According to the Zhitong Finance APP, Gosuncn (300098.SZ) released its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of between 220 million yuan and 320 million yuan, with losses widening; the net loss after deducting non-recurring gains and losses is expected to be between 282 million yuan and 382 million yuan, also with losses widening ### Related Stocks - [300098.CN](https://longbridge.com/en/quote/300098.CN.md) ## Related News & Research - [Fibocom sells Shanghai Faiot industrial handheld unit to Luxshare for RMB 120 million](https://longbridge.com/en/news/296613884.md) - [CirTran GAAP EPS of -$0.02, revenue of $1.17M](https://longbridge.com/en/news/296619459.md) - [Happen SVP, Corporate Controller Fergal Stack disposes of common shares worth $2.15 million](https://longbridge.com/en/news/296547158.md) - [Ipsen reports 83,814,526 shares outstanding, 130,919,315 net voting rights as of July 31, 2026](https://longbridge.com/en/news/296515863.md) - [Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastases](https://longbridge.com/en/news/296323325.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**